It is important to note that Ozempic is not used to treat type 1 diabetes, and is not the same as insulin
These minor changes are often made solely to create the illusion that the patient requires a unique compounded formulation when, in reality, they do not. Whats particularly telling is that many compounding pharmacies are offering the same additives or minor adjustments to large numbers of patientsi.e., mass personalizationwhich clearly demonstrates a violation of FDA requirements for individualized compounding. FDA, Eli Lilly and Novo Nordisk Agree on Compounded GLP-1 Medications The FDA makes it clear: providers should not sell or market compounded GLP-1 medications like semaglutide and tirzepatide unless a patient has a legitimate, documented clinical need
Heres the more encouraging nuance, though: not everyone follows that pattern
And when you're in the sun, use one with SPF protection
If you are considering semaglutide, schedule a consultation with our medical team to discuss your health history, assess whether you are a good candidate, and develop an individualized protocol that maximizes benefits while minimizing potential side effects